• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Cramer: Some Companies Are Done in by Destiny

Losing control can send some, such as Twitter, off the rails.
By JIM CRAMER
Feb 09, 2017 | 11:20 AM EST
Stocks quotes in this article: TWTR, FB, GOOGL, KO, PEP, AGN, PNRA, EMR, CMI, CAT, MU

Destiny. It often comes down to which companies are in charge of their own destiny.

Today the stock of Twitter (TWTR) is down hideously after a pretty decent quarter and many are aghast that it could slash its earnings forecast so drastically and not even offer a revenue outlook.

They shouldn't be. First, Twitter has only so much live-action programming that advertiser's want. Second, sure the president tweets and people go to see what he's tweeting. That's bringing in new users for certain. However, there's been a very big change on the web. For the longest time, when a web company increased users, its advertising revenues would go higher. That's no longer the case because there are so many sites to choose from and because Facebook (FB) and Google (GOOGL) are taking share from everyone -- including, by the way, Snapchat, which will soon have an initial public offering.

You can argue that no one is in charge at Twitter. I would argue that, unlike Facebook and Google, now Alphabet, Twitter's simply not in charge of its destiny.

I think you saw today that Coca-Cola (KO) isn't currently in charge of its destiny because its chief product, soda, is not the growth business it used to be. It's taking action to become leaner, offloading the bottlers, but it doesn't have a model that can put it in control. Contrast that with Action Alerts PLUS holding PepsiCo (PEP) , which has a snack business that makes a ton of money and is a true growth company. CEO Indra Nooyi is in control of PepsiCo's destiny and that's why it should sell at a substantial premium to Coca-Cola. It doesn't yet. I think it will. 

We talked with Allergan (AGN) yesterday and here's another example of a company that's in charge of its own destiny at the same time that the rest of its cohort isn't. While so many of the other big pharma companies need big price increases on their old products, something President Trump doesn't want, Allergan's bought a series of little companies that could produce blockbusters for Allergan. Unlike old drugs, you can charge more for brand new pharmaceuticals that solve big needs, like depression and suicide and non-alcoholic liver disease. CEO Brent Saunders has created a powerhouse with a stock that does not fully reflect it yet.

We know restaurants are a challenged sector where you are always hearing about companies not being able to triumph over the weak consumer. But that's not true. Management at Panera (PNRA) has triumphed over so much, enrolling 25 million people in an affinity plan that is now responsible for 50% of its sales and going digital for 25% of the business. Its delivery business is on fire.

Panera is in charge of its destiny. That's why the stock could rally $19 in a single day. (Facebook, Google, Allergan and Panera are part of TheStreet's Action Alerts PLUS portfolio.) 

Now there are some companies not in charge of their destiny that happen to be in a good part of their cycle. I believe some of the big cyclicals like Emerson (EMR) and Cummins (CMI) and Caterpillar (CAT) have done much good to improve their companies, but it's only because worldwide economies are improving that their stocks are catching bids. Micron's (MU) stock caught a huge upgrade from Bank of America Merrill, going from Sell to Buy, because there are shortages of its DRAM and flash memory products. Micron's distinctly not in control of its destiny. That's just demand overwhelming supply.

Right now, in this market, companies that have destiny in their hands are getting bid up. Those that don't and the cycle's against them? They need a rising tide to lift their stocks, and after this run that's not something I want to bank on.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, is long PEP, FB, GOOGL, AGN and PNRA.

TAGS: Investing | U.S. Equity | Healthcare | Consumer Staples | Basic Materials | Technology | Jim Cramer | Markets | Stocks

More from Healthcare

Trade Carefully With Soaring Gritstone Oncology

Bruce Kamich
Jan 21, 2021 8:16 AM EST

The history we are concerned about is the past couple of weeks.

UnitedHealth Group Charts Appear Toppy Ahead of Earnings

Bruce Kamich
Jan 19, 2021 8:53 AM EST

The technical indicators of the health benefits concern are not sending strong signals at present.

Moderna Now Looks Like an Effective Long Trade With Few Side Effects

Bruce Kamich
Jan 14, 2021 12:06 PM EST

MRNA has corrected its big November rally and now looks ready to start a fresh advance, according to the charts.

Pacific Biosciences Reaches Our Price Target: Now What?

Bruce Kamich
Jan 13, 2021 12:19 PM EST

Let's check out the charts and technical indicators.

Emergent BioSolutions Is Looking Stronger

Bruce Kamich
Jan 12, 2021 10:37 AM EST

Here's an update on EBS shares.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    I discuss price targets in my Saturday column.
  • 07:54 AM EST GARY BERMAN

    Friday Morning Fibocall for 1/22/2021

    SPX (Long-Term View) The 1/21/21 NEW high @ 3861...
  • 11:16 AM EST CHRIS VERSACE

    Worst Stocks to Buy for the Biden Presidency

    Biden's take on the minimum wage, likely moves on ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login